Comparison of analgesic effect of ?suppositories after cesarean section

Comparison of analgesic effect of Diclofenac, Indomethacin. Naproxen and Acetaminophen suppository after cesarean section

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201205139585N1

Enrollment

120

Registered

2012-12-18

Start date

2013-02-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after cesarean section. Pelvic and perineal pain

Interventions

Intervention 1: Indomethacin intervention: A trained personnel without knowing the name of the medication checks the patient's vital signs on arrival in the recovery room, and then a 100 mg Indomethac

Treatment - Drugs

Indomethacin intervention: A trained personnel without knowing the name of the medication checks the patient's vital signs on arrival in the recovery room, and then a 100 mg Indomethacin suppository (

Naproxen Intervention: A trained personnel without knowing the name of the medication checks the patient's vital signs on arrival in the recovery room, and then a 500 mg Naproxen suppository (made by

Diclofenac intervention: a trained personnel without knowing the name of the medication checks the patient's vital signs on arrival in the recovery room, and then a 100 mg Diclofenac suppository (ma

Acetaminophen intervention: a trained personnel without knowing the name of the medication checks the patient's vital signs on arrival in the recovery room, and then a 325mg Acetaminophen suppository

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria: primi gravid, term fetus, 37 week or more pregnancy and patients with 20 to 45 years old and weight of 60 to 80 kg indicated for elective surgery. The exclusion criteria: History of allergy to NSAIDs , Bronchial asthma , History of abdominal surgery, Opium addiction , Previous cesarean section, Hemorrhoid , Proctitis , gestational hypertension, preeclampsia, Bleeding tendency, Gastric ingestion ulcers, liver and kidney disease , Patients that refuse to follow the study or severity of their pain needs use of opioid or other analgesics

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain severity. Timepoint: after drug administration, 15 minutes after drug administration, and an hour later. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMatin Hashemi Shadmehri

Kerman University of Medical Sciences

matinhashemi60@yahoo.com+98 34 1282 0361

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026